This letter from Bob Alexander, Director of NHS Finance, sets out the changes that will be made to the Drug Tariff from April 2011, further to the CPCF funding agreement for 2010/11. Additional adjustments to generic medicine prices and/or fees and allowances may be appropriate later in the year. Primary Care Trust chief executives will wish to consider the local implications with their finance and medicines management leads.
http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_125126
UKCAB 